Synapse - Mikhail Roshal

Results (73)

High-resolution single cell T-cell phenotyping of B-cell lineage lymphomas reveals unique immune signatures and potential targetable vulnerabilities

Meeting Abstract

El Daker, S.; Baik, J.; Dogan, A.; Zhu, M.; Roshal, M.; Galera, P. K.
Blood (2022)

Fulltext@MSK | Save

Single cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia

Meeting Abstract

Robinson, T.; Bowman, R. L.; Persaud, S.; Liu, Y.; Gao, Q.; Zhang, J. P.; Sun, X.; Sciambi, A.; Llanso, A.; Famulare, C.; more...
Blood (2022)

Fulltext@MSK | Save

Stem cell autograft minimal residual disease negativity improves outcomes after autotransplant for multiple myeloma

Meeting Abstract

Nishimura, N.; Brown, S.; Devlin, S. M.; Dahi, P. B.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Hassoun, H.; Hultcrantz, M.; more...
Blood (2022)

Fulltext@MSK | Save

A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy

Correspondence

Nath, K.; Shekarkhand, T.; Salcedo, M.; Derkach, A.; Rueda, S.; Chansakul, A.; Hulcrantz, M.; Korde, N.; Shah, U. A.; Tan, C.; more...
Leukemia and Lymphoma (2022)

Fulltext@MSK | Save

GPRC5D-targeted CAR T cells for myeloma

Journal Article

Mailankody, S.; Devlin, S. M.; Landa, J.; Nath, K.; Diamonte, C.; Carstens, E. J.; Russo, D.; Auclair, R.; Fitzgerald, L.; Cadzin, B.; more...
New England Journal of Medicine (2022)

Fulltext@MSK | Save

Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML

Journal Article

Ramaswamy, K.; Steinherz, P. G.; Agrawal, A. K.; Forlenza, C. J.; Mauguen, A.; Roshal, M.; Trippett, T.; Kernan, N. A.; Sulis, M. L.; Shukla, N.
Blood Advances (2022)

Fulltext@MSK | Save

Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasm

Journal Article

Miltiadous, O.; Petrova-Drus, K.; Kaicker, S.; Mathew, S.; Kluk, M.; Geyer, J. T.; Rodriguez-Sanchez, I.; Bouvier, N.; Inghirami, G.; Stieglitz, E.; more...
Blood Advances (2022)

Fulltext@MSK | Save

Zanubrutinib, obinutuzumab, and venetoclax in chronic lymphocytic leukemia: Early MRD kinetics define a high-risk patient cohort with delayed bone marrow undetectable MRD and earlier post-treatment MRD recurrence

Meeting Abstract

Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E. P.; Barnes, J. A.; Hamilton, A.; more...
Blood (2021)

Fulltext@MSK | Save

Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma

Meeting Abstract

Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
Blood (2021)

Fulltext@MSK | Save

Deep phenotyping reveals expansion of T follicular regulatory cells and triple positive (CTLA4, TIGIT, PD1) exhausted effector memory T cells characterizing the immunosuppressive microenvironment in follicular lymphoma

Meeting Abstract

El Daker, S.; Freeman, D.; Baik, J.; Zhu, M.; Chattopadhyay, P.; Roshal, M.; Dogan, A.; Galera, P.
Blood (2021)

Fulltext@MSK | Save